Sanofi
ANZEMET
Manufacturer:
Sanofi
Name:
ANZEMET
HCPCS Code Descriptor:
Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen
Category:
Q Code
HCPCS:
Q0180
NDC(s):
00088-1202-05, 00088-1203-05,
Primary Type:
Oncology-Anti-Emetic
Generic Status:
Route of Administration:
Oral
About:
ANZEMET is an Oncology-Anti-Emetic drug manufactured by Sanofi and administered via the Oral route of administration. The Q Code: Q0180 is aligned to the drug ANZEMET.